In vivo testing of circulating ovarian tumor cells in the contexts of both thrombocytosis and thrombocytopenia could assist in more accurately pinpointing PAI-1’s position in the metastatic cascade. This evidence concerns the gene SERPINE1 and Thrombocytosis.